Soyer, N. Et Al. 2021. Efficacy and safety of ruxolitinib in patients with myelofibrosis: A retrospective and multicenter experience in turkey. Turkish Journal of Medical Sciences , vol.51, no.3 , 1033-1042.

Soyer, N., Ali, R., Turgut, M., HAZNEDAROĞLU, İ. C., Yilmaz, F., Aydoğdu, İ., ... Pir, A.(2021). Efficacy and safety of ruxolitinib in patients with myelofibrosis: A retrospective and multicenter experience in turkey. Turkish Journal of Medical Sciences , vol.51, no.3, 1033-1042.

Soyer, Nur Et Al. "Efficacy and safety of ruxolitinib in patients with myelofibrosis: A retrospective and multicenter experience in turkey," Turkish Journal of Medical Sciences , vol.51, no.3, 1033-1042, 2021

Soyer, Nur Et Al. "Efficacy and safety of ruxolitinib in patients with myelofibrosis: A retrospective and multicenter experience in turkey." Turkish Journal of Medical Sciences , vol.51, no.3, pp.1033-1042, 2021

Soyer, N. Et Al. (2021) . "Efficacy and safety of ruxolitinib in patients with myelofibrosis: A retrospective and multicenter experience in turkey." Turkish Journal of Medical Sciences , vol.51, no.3, pp.1033-1042.

@article{article, author={Nur Soyer Et Al. }, title={Efficacy and safety of ruxolitinib in patients with myelofibrosis: A retrospective and multicenter experience in turkey}, journal={Turkish Journal of Medical Sciences}, year=2021, pages={1033-1042} }